Ribosomal protein L6 pseudogene 13 (RPL6P13)

Ribosomal protein L6 pseudogene 13 is classified as a processed pseudogene in the human genome[1][5][8]. Pseudogenes like RPL6P13 are typically fragments or nonfunctional copies of protein-coding genes—here, the functional parent being the ribosomal protein L6 gene (RPL6)[7]. Such pseudogenes arise through retrotransposition or other duplication events and generally lack the capacity to produce functional proteins due to mutations, frameshifts, or premature stop codons[7]. There is no evidence of RPL6P13 acting as a protein product or having direct biological or pathological significance as a target, receptor, enzyme, or biomarker in human medicine or pharmacology[5]. RPL6P13 is a pseudogene derived from the ribosomal protein L6 gene and does not make a functional protein[1][2][5][8]. It is not a therapeutic target, has no drug interactions, and is not tied to any recognized biological functions or disease processes[5][7]. Its only relevance is as a genomic landmark in studies of ribosomal pseudogenes and human genome evolution[7].

Other names

RPL6_10_498RPL6P13